Literature DB >> 15074858

Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.

Mark T Donaldson1, Alec J R Jorgensen, Jill Beech.   

Abstract

OBJECTIVE: To determine prevalence and clinical features of pituitary pars intermedia dysfunction (PPID) in horses with laminitis.
DESIGN: Case series. ANIMALS: 40 horses with laminitis. PROCEDURES: Horses with laminitis that survived an initial episode of pain and were not receiving medications known to alter the hypothalamic-pituitary-adrenal axis were tested for PPID by evaluation of endogenous plasma ACTH concentration. Signalment, suspected cause, month of onset and duration of laminitis, Obel grade of lameness, pedal bone rotation, physical examination findings, results of endocrine function tests, treatment, outcome, and postmortem examination findings were recorded.
RESULTS: Prevalence of PPID as defined by a single high plasma ACTH concentration was 70%. Median age of horses suspected of having PPID (n = 28) was 15.5 years, and median age of horses without PPID (12) was 14.5 years. Laminitis occurred most frequently in horses with and without suspected PPID during September and May, respectively. Chronic laminitis was significantly more common in horses suspected of having PPID. In horses suspected of having PPID, the most common physical examination findings included abnormal body fat distribution, bulging supraorbital fossae, and hirsutism. Five horses suspected of having PPID had no clinical abnormalities other than laminitis. Seventeen horses suspected of having PPID that were treated with pergolide survived, and 3 horses that were not treated survived. CONCLUSIONS AND CLINICAL RELEVANCE: Evidence of PPID is common among horses with laminitis in a primary-care ambulatory setting. Horses with laminitis may have PPID without other clinical signs commonly associated with the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15074858     DOI: 10.2460/javma.2004.224.1123

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  8 in total

1.  Equine pituitary pars intermedia dysfunction: An international survey of veterinarians' approach to diagnosis, management, and estimated prevalence.

Authors:  James L Carmalt; Cheryl L Waldner; Andrew L Allen
Journal:  Can J Vet Res       Date:  2017-10       Impact factor: 1.310

2.  The effect of tumour necrosis factor-α and insulin on equine digital blood vessel function in vitro.

Authors:  Nicola J Menzies-Gow; H Wray; S R Bailey; P A Harris; J Elliott
Journal:  Inflamm Res       Date:  2014-04-24       Impact factor: 4.575

3.  Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.

Authors:  D I Rendle; M Duz; J Beech; T Parkin; A E Durham
Journal:  J Vet Intern Med       Date:  2014-10-13       Impact factor: 3.333

4.  Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.

Authors:  Melody A de Laat; Martin N Sillence; Dania B Reiche
Journal:  J Vet Intern Med       Date:  2019-01-29       Impact factor: 3.333

5.  A "modified Obel" method for the severity scoring of (endocrinopathic) equine laminitis.

Authors:  Alexandra Meier; Melody de Laat; Christopher Pollitt; Donald Walsh; James McGree; Dania B Reiche; Marcella von Salis-Soglio; Luke Wells-Smith; Ulrich Mengeler; Daniel Mesa Salas; Susanne Droegemueller; Martin N Sillence
Journal:  PeerJ       Date:  2019-06-07       Impact factor: 2.984

6.  Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol.

Authors:  Elizabeth Hodge; Alycia Kowalski; Catherine Torcivia; Sue Lindborg; Darko Stefanovski; Kelsey Hart; Nicholas Frank; Andrew van Eps
Journal:  J Vet Intern Med       Date:  2019-08-20       Impact factor: 3.333

7.  Pituitary Pars Intermedia Dysfunction and Metabolic Syndrome in Donkeys.

Authors:  Heidrun Gehlen; Bianca Schwarz; Claus Bartmann; Jennifer Gernhardt; Sabita D Stöckle
Journal:  Animals (Basel)       Date:  2020-12-08       Impact factor: 2.752

Review 8.  Regenerative Medicine for Equine Musculoskeletal Diseases.

Authors:  Iris Ribitsch; Gil Lola Oreff; Florien Jenner
Journal:  Animals (Basel)       Date:  2021-01-19       Impact factor: 2.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.